Asa Henin

Partner
ahenin@cooley.com
Full contact info

About Asa

Asa’s practice focuses on representing publicly traded life sciences companies as primary outside corporate and securities counsel. He advises management and boards of directors on US Securities and Exchange Commission (SEC) reporting and disclosure requirements, proxy statements and shareholder meetings, stock exchange requirements, corporate governance, investor communications, and other corporate and securities matters. Asa also advises companies in connection with their pre-initial public offering (IPO) crossover financings, IPOs, follow-on public offerings, and private investment in public equity (PIPE) financings. He is a member of Cooley’s public company advisory team (PCAT).

View full bio

Experience

Inmagene Biopharmaceuticals Announces Merger With Ikena Oncology

Inmagene Biopharmaceuticals Announces Merger With Ikena Oncology

December 23, 2024

Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Asa Henin
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Brittany K. Wightman
Associate, San Diego
Jiqiang Lin
Associate, New York
Leina Verrier
Associate, Santa Monica
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Howard Morse
Senior Counsel, Washington, DC
Alessandra Murata
Partner, Palo Alto
Jean Park
Partner, New York
Aaron Pomeroy
Partner, Colorado
Michelle Garcia Schulman
Partner, Reston
Ellie Seber
Partner, Santa Monica
Marty Schenker
Senior Counsel , San Francisco
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Stella Sarma
Partner, Brussels
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Rajdeep Roger Bains
Associate, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Adrienne Beaudoin Deshmukh
Associate, Reston
Jeremy M. Exelbert
Associate, New York
Zack Gong
Associate, Shanghai
Rick Jantz
Associate, Santa Monica
Wyatt Kernell
Associate, Colorado
Rebeca Kinslow
Associate, San Diego
Hilda Li
Associate, Hong Kong
Lunga Su
Associate, Shanghai
Novak Topalovic
Associate, San Diego
Tania Soris
Associate, New York
Christine Tse
Associate, New York
Monica Xu
Special Counsel, Shanghai
Sai Yarramalla
Associate, Palo Alto
Andy Zachrich
Associate, San Francisco
Patricia Myers
Paralegal Specialist, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

Mergers and Acquisitions
Life Sciences
Biotechnology
Healthcare
Public Companies

Personalis Announces Expanded Collaboration With Tempus AI

Personalis Announces Expanded Collaboration With Tempus AI

August 16, 2024

Cooley advised Personalis, a company transforming the active management of cancer through breakthrough personalized testing, on its expanded commercial relationship with Tempus AI, including an equity investment by Tempus into Personalis.

Read more

Related contacts

Bill Roegge
Partner, New York
Laura Berezin
Partner, Seattle
Asa Henin
Partner, San Diego
Patrick Pang
Associate, New York
Allison Peth
Associate, Palo Alto
Jeewon Lee
Associate, New York
Matthew Choy
Associate, New York
Megan Browdie
Partner, Washington, DC
David Burns
Special Counsel, Washington, DC

Related Practices & Industries

Healthcare
Life Sciences
Mergers and Acquisitions
Life Sciences Corporate Partnering and Licensing
Public Companies
Antitrust and Competition
Securities Litigation + Enforcement

Cidara Therapeutics Announces Concurrent Reacquisition of IP Rights to CD388, $240 Million PIPE Financing

Cidara Therapeutics Announces Concurrent Reacquisition of IP Rights to CD388, $240 Million PIPE Financing

May 1, 2024

Cooley advised Cidara Therapeutics (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak platform to develop drug-Fc conjugate immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, on its concurrent $240 million private placement financing and definitive agreement with Janssen Pharmaceuticals, a Johnson & Johnson Company, to reacquire the exclusive global development and commercial rights to CD388.

Read more

Related contacts

Charles Bair
Partner, San Diego
Jane Adams
Partner, San Diego
Barbara Borden
Senior Counsel, San Diego
Megan Browdie
Partner, Washington, DC
Daniel I. Goldberg
Partner, New York
Aaron Pomeroy
Partner, Colorado
Richard Segal
Partner, New York
Francis Wheeler
Senior Counsel, Colorado
Sharon Connaughton
Special Counsel, Washington, DC
Asa Henin
Partner, San Diego
Alexis Guillermo Buz
Associate, San Diego
Gaël Y. Hagan
Special Counsel , Colorado
Michelle Hunt
Associate
Edmond Lay
Partner, San Diego
Kyrsten Lundh
Associate, San Diego
Jayden Martinez
Associate, Colorado
Amanda Pacheco
Associate, Palo Alto
Valerie Sapozhnikova
Associate, Los Angeles
Kelly Nelle
Paralegal Specialist, San Diego

Related Practices & Industries

Biotechnology
Life Sciences
Life Sciences Corporate Partnering and Licensing
Intellectual Property
Mergers and Acquisitions
Public Companies
Capital Markets
Antitrust and Competition
Tax

MannKind Announces up to $200 Million Royalty Purchase Agreement With Sagard Healthcare

MannKind Announces up to $200 Million Royalty Purchase Agreement With Sagard Healthcare

January 2, 2024

Cooley advised MannKind, a company focusing on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases, on the sale of a 1% royalty in net sales of Tyvaso DPI (treprostinil) inhalation powder to Sagard Healthcare for up to $200 million.

Read more

Related contacts

Matt Browne
Partner, San Diego
Amy Hallman Rice
Special Counsel, San Diego
Pitrina Gilger
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Mischi a Marca
Partner, San Francisco
Matthew S. Scarano
Associate, San Diego
Asa Henin
Partner, San Diego
Michelle Hunt
Associate
Chris Rhem
Paralegal Specialist, San Francisco

Related Practices & Industries

Emerging Companies
Venture Capital
Mergers and Acquisitions
Healthcare
Life Sciences
Tax
Debt Finance
Public Companies

Travere Sells Bile Acid Product Portfolio to Mirum

Travere Sells Bile Acid Product Portfolio to Mirum

July 18, 2023

Cooley advised Travere Therapeutics, a biopharmaceutical company, on its definitive agreement to sell its bile acid product portfolio to Mirum Pharmaceuticals.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Charity Williams
Partner, San Diego
John Forrest
Associate, Boston
David Burns
Special Counsel, Washington, DC
Jeffrey J. Tolin
Partner, New York
Ross Eberly
Partner, Santa Monica
Natasha Leskovsek
Of Counsel, Washington, DC
Peter Adams
Partner, San Diego
Rachel Thorn
Of counsel, New York
Alessandra Murata
Partner, Palo Alto
Cara Buchicchio
Associate, New York
Tony P. Guan
Associate, Santa Monica
Lei Shen
Partner, Chicago
Allison Kutner
Associate, New York
Patrick Van Eecke
Partner, Brussels
Wyatt Kernell
Associate, Colorado
Asa Henin
Partner, San Diego

Related Practices & Industries

Mergers and Acquisitions
Life Sciences
Healthcare
Antitrust and Competition
Tax
Labor and Employment
Compensation and Benefits
Public Companies
Cyber/Data/Privacy
Arbitration
Commercial Litigation
View more

Admissions and credentials

California

Rankings and accolades

CALI Awards in Corporations and Securities Regulation, Recipient

Memberships and affiliations

The State Bar of California